Data Insights

CHOH-01 by CHO Pharma for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in B-Cell Non-Hodgkin Lymphoma

Data Insights

CHOH-01 by CHO Pharma for Follicular Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in Follicular Lymphoma

Data Insights

CHOH-01 by CHO Pharma for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in Diffuse Large B-Cell Lymphoma

Data Insights

CHOH-01 by CHO Pharma for Marginal Zone B-cell Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for Marginal Zone B-cell Lymphoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in Marginal Zone B-cell Lymphoma

Data Insights

CHOH-01 by CHO Pharma for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for Primary Mediastinal B-Cell Lymphoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in Primary Mediastinal B-Cell Lymphoma

Data Insights

CHOH-01 by CHO Pharma for Mantle Cell Lymphoma: Likelihood of Approval

CHOH-01 is under clinical development by CHO Pharma and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - CHOH-01 in Mantle Cell Lymphoma